410 related articles for article (PubMed ID: 17365825)
1. The pathology of gestational trophoblastic disease: recent advances.
Wells M
Pathology; 2007 Feb; 39(1):88-96. PubMed ID: 17365825
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of p57kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease.
Chilosi M; Piazzola E; Lestani M; Benedetti A; Guasparri I; Granchelli G; Aldovini D; Leonardi E; Pizzolo G; Doglioni C; Menestrina F; Mariuzzi GM
Lab Invest; 1998 Mar; 78(3):269-76. PubMed ID: 9520940
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemistry of choriocarcinoma: an aid in differential diagnosis and in elucidating pathogenesis.
Mao TL; Kurman RJ; Huang CC; Lin MC; Shih IeM
Am J Surg Pathol; 2007 Nov; 31(11):1726-32. PubMed ID: 18059230
[TBL] [Abstract][Full Text] [Related]
4. Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole.
Lurain JR
Am J Obstet Gynecol; 2010 Dec; 203(6):531-9. PubMed ID: 20728069
[TBL] [Abstract][Full Text] [Related]
5. Current issues in the histopathology of gestational trophoblastic tumors.
Sebire NJ; Lindsay I
Fetal Pediatr Pathol; 2010; 29(1):30-44. PubMed ID: 20055562
[TBL] [Abstract][Full Text] [Related]
6. p57(KIP2) immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancy.
Sebire NJ; Rees HC; Peston D; Seckl MJ; Newlands ES; Fisher RA
Histopathology; 2004 Aug; 45(2):135-41. PubMed ID: 15279631
[TBL] [Abstract][Full Text] [Related]
7. Intraplacental choriocarcinoma arising in a second trimester placenta with partial hydatidiform mole.
Medeiros F; Callahan MJ; Elvin JA; Dorfman DM; Berkowitz RS; Quade BJ
Int J Gynecol Pathol; 2008 Apr; 27(2):247-51. PubMed ID: 18317216
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic aspects of hydatidiform mole with persistence of polymorphic trophoblastic hyperplasia.
Makovitzky J; Vogel M; Miessner R; Mylonas I; Vogt-Weber B; Richter DU
Anticancer Res; 2003; 23(2A):1069-73. PubMed ID: 12820349
[TBL] [Abstract][Full Text] [Related]
9. Characterization of androgenetic/biparental mosaic/chimeric conceptions, including those with a molar component: morphology, p57 immnohistochemistry, molecular genotyping, and risk of persistent gestational trophoblastic disease.
Lewis GH; DeScipio C; Murphy KM; Haley L; Beierl K; Mosier S; Tandy S; Cohen DS; Lytwyn A; Elit L; Vang R; Ronnett BM
Int J Gynecol Pathol; 2013 Mar; 32(2):199-214. PubMed ID: 23370656
[TBL] [Abstract][Full Text] [Related]
10. [The early placental trophoblast. II. Tumorous disorders of trophoblast development].
Horn LC; Emmrich P; Bilek K; Bruder E
Zentralbl Gynakol; 1996; 118(11):591-7. PubMed ID: 9082691
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic value of p27 in comparison to p57 in differentiation between different gestational trophoblastic diseases.
Abdou A; Kandil M; El-Wahed MA; Shabaan M; El-Sharkawy M
Fetal Pediatr Pathol; 2013 Dec; 32(6):395-411. PubMed ID: 23438793
[TBL] [Abstract][Full Text] [Related]
12. Trophoblastic lesions of the placental site.
Baergen RN; Rutgers JL
Gen Diagn Pathol; 1997 Nov; 143(2-3):143-58. PubMed ID: 9443571
[TBL] [Abstract][Full Text] [Related]
13. Histopathological diagnosis of hydatidiform mole: contemporary features and clinical implications.
Sebire NJ
Fetal Pediatr Pathol; 2010; 29(1):1-16. PubMed ID: 20055560
[TBL] [Abstract][Full Text] [Related]
14. Relaxation of imprinting in trophoblastic disease.
Ariel I; Lustig O; Oyer CE; Elkin M; Gonik B; Rachmilewitz J; Biran H; Goshen R; de Groot N; Hochberg A
Gynecol Oncol; 1994 May; 53(2):212-9. PubMed ID: 8188082
[TBL] [Abstract][Full Text] [Related]
15. Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor.
Tuncer ZS; Vegh GL; Fulop V; Genest DR; Mok SC; Berkowitz RS
Gynecol Oncol; 2000 Jun; 77(3):389-93. PubMed ID: 10831347
[TBL] [Abstract][Full Text] [Related]
16. Indoleamine 2,3-dioxygenase expression in gestational trophoblastic disease: implications for development of immunotherapeutic approaches.
Sebire NJ; Fisher RA; Williams S; Prendergast G; Savage P; Seckl M
J Reprod Med; 2008 Oct; 53(10):789-92. PubMed ID: 19004406
[TBL] [Abstract][Full Text] [Related]
17. P63 expression in hydropic abortion and gestational trophoblastic diseases.
Ramalho LN; Maggiori MS; Ribeiro-Silva A; Peres LC
Placenta; 2006; 27(6-7):740-3. PubMed ID: 16026831
[TBL] [Abstract][Full Text] [Related]
18. New concepts in trophoblastic growth and differentiation with practical application for the diagnosis of gestational trophoblastic disease.
Shih IM; Kurman RJ
Verh Dtsch Ges Pathol; 1997; 81():266-72. PubMed ID: 9474880
[TBL] [Abstract][Full Text] [Related]
19. Problems and pitfalls in the histopathologic diagnosis of gestational trophoblastic lesions.
Driscoll SG
J Reprod Med; 1987 Sep; 32(9):623-8. PubMed ID: 2822915
[TBL] [Abstract][Full Text] [Related]
20. [Expression of p57 marker in differential diagnosis of complete and partial mole - correlation with DNA analysis].
Cierna Z; Palkovič M; Danihel Ml L; Danihel L; Repiská V; Vojtaššák J; Korbeľ M
Cesk Patol; 2012 Oct; 48(4):218-21. PubMed ID: 23121032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]